Advertisement

Acceptability and Usability of Self-Collected Sampling for HPV Testing Among African-American Women Living in the Mississippi Delta

Published:February 14, 2013DOI:https://doi.org/10.1016/j.whi.2012.12.003

      Abstract

      Background

      Human papillomavirus (HPV) DNA testing has been shown to be an effective approach to cervical cancer screening, and self-collection sampling for HPV testing could be a potential alternative to Pap test, provided that women who tested positive by any method get timely follow-up and care. This feasibility study examined acceptability and usability of self-collected sampling for HPV testing among African-American (AA) women in the Mississippi Delta to inform the development of interventions to promote cervical cancer screening in this population.

      Methods

      The study consisted of two phases. Phase I consisted of eight focus groups (n = 87) with AA women to explore knowledge, attitudes, and beliefs about cervical cancer and HPV infection as well as acceptability of self-collected sampling for HPV testing. In phase II, we examined the usability of this technology through one discussion group (n = 9). The Health Belief Model guided data collection and analysis.

      Results

      Although participants perceived themselves as susceptible to cervical cancer and acknowledged its severity, there was a lack of knowledge of the link between HPV and cervical cancer, and they expressed a number of misconceptions. The most frequent barriers to screening included embarrassment, discomfort, and fear of the results. Women in both phases were receptive to self-collected sampling for HPV testing. All participants in the usability phase expressed that self-collection was easy and they did not experience any difficulties.

      Conclusion

      Self-collection for HPV testing is an acceptable and feasible method among AA women in the Mississippi Delta to complement current cytology cervical cancer screening programs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Balasubramanian A.
        • Kulasingam S.L.
        • Baer A.
        • Hughes J.P.
        • Myers E.R.
        • Mao C.
        • et al.
        Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
        Journal of Lower Genital Tract Disease. 2010; 14: 185-195
        • Behbakht K.
        • Lynch A.
        • Teal S.
        • Degeest K.
        • Massad S.
        Social and cultural barriers to Papanicolaou test screening in an urban population.
        Obstetrics and Gynecology. 2004; 104: 1355-1361
        • Belinson J.L.
        • Hu S.
        • Niyazi M.
        • Pretorius R.G.
        • Wang H.
        • Wen C.
        • et al.
        Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
        International Journal of Cancer. 2010; 127: 1151-1157
        • Belinson J.L.
        • Qiao Y.L.
        • Pretorius R.G.
        • Zhang W.H.
        • Rong S.D.
        • Huang M.N.
        • et al.
        Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.
        International Journal of Gynecological Cancer. 2003; 13: 819-826
        • Borelli B.
        Smoking cessation: next steps for special populations research and innovative treatments.
        Journal of Consulting and Clinical Psychology. 2010; 78: 1-12
        • Brewster W.R.
        • Hubbell F.A.
        • Largent J.
        • Ziogas A.
        • Lin F.
        • Howe S.
        • et al.
        Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
        Journal of the American Medical Association. 2005; 294: 2182-2187
        • Burnett C.B.
        • Steakley C.S.
        • Tefft M.C.
        Barriers to breast and cervical cancer screening in underserved women of the District of Columbia.
        Oncology Nursing Forum. 1995; 22: 1551-1557
        • Castle P.E.
        • Aftab A.
        • Saint-Jean G.
        • Mendez L.
        Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device.
        Journal of Clinical Microbiology. 2006; 44: 2158-2159
        • Castle P.E.
        • Glass A.G.
        • Rush B.B.
        • Scott D.R.
        • Wentzensen N.
        • Gage J.C.
        • et al.
        Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
        Journal of Clinical Oncology. 2012; 30: 3044-3050
        • Castle P.E.
        • Rausa A.
        • Walls T.
        • Gravitt P.E.
        • Partridge E.E.
        • Olivo V.
        • et al.
        Comparative community outreach to increase cervical cancer screening in the Mississippi Delta.
        Preventive Medicine. 2011; 52: 452-455
        • Castle P.E.
        • Sadorra M.
        • Garcia F.A.
        • Cullen A.P.
        • Lorincz A.T.
        • Mitchell A.L.
        • et al.
        Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.
        Cancer Epidemiology, Biomarkers, and Prevention. 2007; 16: 840-843
        • Castle P.E.
        • Stoler M.H.
        • Wright Jr., T.C.
        • Sharma A.
        • Wright T.L.
        • Behrens C.M.
        Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
        Lancet Oncology. 2011; 12: 880-890
        • Cates J.R.
        • Brewer N.T.
        • Fazekas K.I.
        • Mitchell C.E.
        • Smith J.S.
        Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women.
        Journal of Rural Health. 2009; 25: 93-97
      1. Centers for Disease Control and Prevention. (N.D.) Alabama National Breast and Cervical Early Detection Program. Available from: http://www.cdc.gov/cancer/nbccedp/data/summaries/alabama.

      2. Cervix cancer screening. IARC handbooks of cancer prevention. IARC Press, Lyon, France2005
        • Chernesky M.A.
        • Hook 3rd, E.W.
        • Martin D.H.
        • Lane J.
        • Johnson R.
        • Jordan J.A.
        • et al.
        Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections.
        Sexually Transmitted Disease. 2005; 32: 729-733
        • Cuzick J.
        • Clavel C.
        • Petry K.U.
        • Meijer C.J.
        • Hoyer H.
        • Ratnam S.
        • et al.
        Overview of the European and North American studies on HPV testing in primary cervical cancer screening.
        International Journal of Cancer. 2006; 119: 1095-1101
        • De Alba I.
        • Anton-Culver H.
        • Hubbell F.A.
        • Ziogas A.
        • Hess J.R.
        • Bracho A.
        • et al.
        Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women.
        Cancer Epidemiology, Biomarkers & Prevention. 2008; 17: 2163-2168
        • Dillner J.
        • Rebolj M.
        • Birembaut P.
        • Petry K.U.
        • Szarewski A.
        • Munk C.
        • et al.
        Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.
        British Medical Journal. 2008; 337: a1754
        • D'Urso J.
        • Thompson-Robinson M.
        • Chandler S.
        HPV knowledge and behaviors of black college students at a historically black university.
        Journal of American College Health. 2007; 56: 159-163
        • Edwards B.K.
        • Ward E.
        • Kohler B.A.
        • Eheman C.
        • Zauber A.G.
        • Anderson R.N.
        • et al.
        Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.
        Cancer. 2010; 116: 544-573
        • Fouad M.N.
        • Nagy M.C.
        • Johnson R.E.
        • Wynn T.A.
        • Patridge E.E.
        • Dignan M.
        The development of a community action plan to reduce breast and cervical cancer disparities between African-American and white women.
        Ethnicity & Disease. 2004; 14: S53-S60
        • Freeman H.P.
        • Wingrove B.K.
        Excess cervical cancer mortality: a marker for low access to health care in poor communities.
        (NIH Pub. No. 05–5282) National Institutes of Health, Bethesda, MD2007
        • Gage J.C.
        • Partridge E.E.
        • Rausa A.
        • Gravitt P.E.
        • Wacholder S.
        • Schiffman M.
        • et al.
        Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
        Journal of Clinical Microbiology. 2011; 49: 4185-4189
        • Garcia F.
        • Barker B.
        • Santos C.
        • Brown E.M.
        • Nuño T.
        • Giuliano A.
        • et al.
        Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus.
        Obstetrics and Gynecology. 2003; 102: 266-272
        • Gravitt P.E.
        • Lacey Jr., J.V.
        • Brinton L.A.
        • Barnes W.A.
        • Kornegay J.R.
        • Greenberg M.D.
        • et al.
        Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
        Cancer Epidemiology, Biomarkers and Prevention. 2001; 10: 95-100
        • Harper D.M.
        • Hildesheim A.
        • Cobb J.L.
        • Greenberg M.
        • Vaught J.
        • Lorincz A.T.
        Collection devices for human papillomavirus.
        Journal of Family Practice. 1999; 48: 531-535
        • Harper D.M.
        • Longacre M.R.
        • Noll W.M.
        • Belloni D.R.
        • Cole B.F.
        Factors affecting the detection rate of human papillomavirus.
        Annals of Family Medicine. 2003; 1: 221-227
        • Harper D.M.
        • Noll W.W.
        • Belloni D.R.
        • Cole B.F.
        Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed–biologic concordance and women's preferences.
        American Journal of Obstetrics and Gynecology. 2002; 186: 365-373
        • Hoyo C.
        • Yarnall K.S.
        • Skinner C.S.
        • Moorman P.G.
        • Sellers D.
        • Reid L.
        Pain predicts non-adherence to Pap smear screening among middle-aged African American women.
        Preventive Medicine. 2005; 41: 439-445
        • Jemal A.
        • Siegel R.
        • Xu J.
        • Ward E.
        Cancer statistics, 2010.
        CA: Cancer Journal for Clinicians. 2010; 60: 277-300
        • Jennings K.M.
        Getting a Pap smear: Focus group responses of African American and Latina women.
        Oncology Nursing Forum. 1997; 24: 827-835
        • Jennings-Dozier K.
        Predicting intentions to obtain a Pap smear among African American and Latina women: testing the theory of planned behavior.
        Nursing Research. 1999; 48: 198-205
        • Kahn J.A.
        • Slap G.B.
        • Huang B.
        • Rosenthal S.L.
        • Wanchick A.M.
        • Kollar L.M.
        • et al.
        Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus.
        Obstetrics and Gynecology. 2004; 105: 952-959
        • Lenselink C.H.
        • de Bie R.P.
        • van Hamont D.
        • Bakkers J.M.
        • Quint W.G.
        • Massuger L.F.
        • et al.
        Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: New possibilities for cervical cancer screening.
        Journal of Clinical Microbiology. 2009; 47: 2564-2570
        • Lindau S.T.
        • Hoffmann J.N.
        • Lundeen K.
        • Jaszczak A.
        • McClintock M.K.
        • Jordan J.A.
        Vaginal self-swab specimen collection in a home-based survey of older women: Methods and applications.
        Journals of Gerontology: Series B, Psychological Sciences and Social Sciences. 2009; 64: i106-i118
        • Lisovicz N.
        • Johnson R.E.
        • Higginbotham J.
        • Downey J.A.
        • Hardy C.M.
        • Fouad M.N.
        • et al.
        The Deep South Network for cancer control. Building a community infrastructure to reduce cancer health disparities.
        Cancer. 2006; 107: 1971-1979
        • Lisovicz N.
        • Wynn T.
        • Fouad M.
        • Partridge E.E.
        Cancer health disparities: what we have done.
        American Journal of Medical Sciences. 2008; 335: 254-259
        • Mayrand M.H.
        • Duarte-Franco E.
        • Rodrigues I.
        • Walter S.D.
        • Hanley J.
        • Ferenczy A.
        • et al.
        Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
        New England Journal of Medicine. 2007; 357: 1579-1588
      3. Mississippi Cancer Registry. Cervical cancer incidence and mortality, 2003-2007. Available from: http://www.cancer-rates.info.

        • Morrison E.A.B.
        • Goldberg G.L.
        • Hagan R.J.
        • Kadish A.S.
        • Burk R.D.
        Self-administered home cervicovaginal lavage: A novel tool for the clinical- epidemiologic investigation of genital human papillomavirus infections.
        American Journal of Obstetrics and Gynecology. 1992; 167: 104-107
        • Moscicki A.B.
        Comparison between methods for human papillomavirus DNA testing: a model for self-testing in young women.
        Journal of Infectious Diseases. 1993; 167: 723-725
        • Naucler P.
        • Ryd W.
        • Törnberg S.
        • Strand A.
        • Wadell G.
        • Elfgren K.
        • et al.
        Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
        New England Journal of Medicine. 2007; 357: 1589-1597
        • Ogilvie G.
        • Krajden M.
        • Maginley J.
        • Isaac-Renton J.
        • Hislop G.
        • Elwood-Martin R.
        • et al.
        Feasibility of self-collection of specimens for human papillomavirus testing in hard to reach women.
        Canadian Medical Association Journal. 2007; 177: 480-483
        • Palmisano M.E.
        • Gaffga A.M.
        • Daigle J.
        • Brinkman J.
        • Mire K.
        • Lenczyk K.
        • et al.
        Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs.
        International Journal of STD & AIDS. 2003; 14: 560-567
        • Partridge E.
        • Fouad M.
        Community-driven approaches for reducing health disparities in cancer.
        Journal of the American Medical Association. 2010; 303: 1090-1091
        • Rijkaart D.C.
        • Berkhof J.
        • Rozendaal L.
        • van Kemenade F.J.
        • Bulkmans N.W.
        • Heideman D.A.
        • et al.
        Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial.
        Lancet Oncology. 2012; 13: 78-88
        • Rompalo A.M.
        • Gaydos C.A.
        • Shah N.
        • Tennant M.
        • Crotchfelt K.A.
        • Madico G.
        • et al.
        Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women.
        Clinical Infectious Diseases. 2001; 33: 1455-1461
        • Ronco G.
        • Giorgi-Rossi P.
        • Carozzi F.
        • Confortini M.
        • Dalla Palma P.
        • Del Mistro A.
        • et al.
        Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial.
        Lancet Oncology. 2010; 11: 249-257
        • Rosenstock I.M.
        The Health Belief Model: explaining health behavior through expectancies.
        in: Glanz K. Lewis F.M. Rimer B.K. Health behavior and health education: Theory, research, and practice. Jossey-Bass, San Francisco1990: 39-61
        • Sankaranarayanan R.
        • Nene B.M.
        • Shastri S.S.
        • Jayant K.
        • Muwonge R.
        • Budukh A.M.
        • et al.
        HPV screening for cervical cancer in rural India.
        New England Journal of Medicine. 2009; 360: 1385-1394
        • Scarinci I.C.
        • Garcia F.A.
        • Kobetz E.
        • Partridge E.E.
        • Brandt H.M.
        • Bell M.C.
        • et al.
        Cervical cancer prevention: new tools and old barriers.
        Cancer. 2010; 116: 2531-2542
        • Scarinci I.C.
        • Johnson R.E.
        • Hardy C.
        • Marron J.
        • Partridge E.E.
        Planning and implementation of a participatory evaluation strategy: A viable approach in the evaluation of community-based participatory programs addressing cancer disparities.
        Program Planning and Evaluation. 2009; 32: 221-228
        • Submaniam A.
        • Fauci J.M.
        • Schneider K.E.
        • Whitworth J.M.
        • Erickson B.K.
        • et al.
        Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?.
        Journal of Lower Genital Tract Disease. 2011; 15: 110-113
      4. U.S. Census. Factfinder Mississippi. Available from: http://factfinder.census.gov/home.

        • Zhao F.H.
        • Lewkowitz A.K.
        • Chen F.
        • Lin M.J.
        • Hu S.Y.
        • Zhang X.
        • et al.
        Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
        Journal of the National Cancer Institute. 2012; 104: 178-188

      Biography

      Isabel C. Scarinci, PhD, MPH, is a professor at the University of Alabama at Birmingham. Her primary area of interest is development, implementation, and evaluation of community-based cancer prevention and control programs that are theoretically based and culturally relevant to African Americans and Latinos.

      Biography

      Allison G. Litton, DrPH, MSW, is a public health evaluation consultant and contributing public health faculty for Walden University. Her research and teaching interests are in program evaluation and health disparities in diverse populations.

      Biography

      Isabel C. Garcés-Palacio, DrPH, is a cancer researcher, professor of the epidemiology group of the School of Public Health at University of Antioquia in Medellin, Colombia. Her research interest focuses primarily on cervical and breast cancer prevention in underserved populations.

      Biography

      Edward E. Partridge, MD, is the director of the UAB Comprehensive Cancer Center. He is the PI of the NCI-funded Deep South Network for Cancer Control, a community-based collaborative effort addressing cancer prevention and control among African Americans in Alabama and Mississippi.

      Biography

      Philip E. Castle, PhD, MPH, is the Executive Director of the Global Cancer Initiative and a Visiting Professor at Albert Einstein College of Medicine. His primary research interests are the epidemiology/natural history of human papillomavirus and cervical cancer and the application of that knowledge for cervical cancer prevention.